Seeing Machines Ltd (AIM:SEE, OTC:SEEMF)’s 16th new contract in the automotive sector has reassured Stifel analysts of the AI-based monitoring technology group’s investment thesis.
Stifel noted that the initial US$15 million contract “was one of the few awards we have seen in the industry in recent months”, adding that it comes from an existing tier-one customer for an existing OEM in Europe.
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) said the third quarter just ended was its strongest quarterly production performance this year at 281,000 ounces of gold.
Costs were also lower quarter-on-quarter at US$967 an ounce, though net income for the three months to the end of September 2023 dropped to US$60 million.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has announced the launch of the Portrait PD-L1 test that will be used to support cancer therapy studies.
Leveraging the company's Parsortix system, this advanced technology enables the harvesting of circulating tumour cells (CTCs) from a patient's blood, providing a less invasive and more dynamic way to monitor cancer progression and response to treatments.
In a strategic move to strengthen its management team, Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has announced the appointment of key former executives from Amryt Pharma, underscoring its commitment to advancing its clinical assets.
Chairman Cathal Friel, who co-founded both Poolbeg and Amryt, will spearhead a similar strategic approach followed by Amryt, which successfully developed drugs for unmet medical needs and bought in commercial assets before being sold for just shy of US$1.5 billion.
Galliford Try Holdings PLC (LSE:GFRD) said it has strengthened its capabilities in the water sector and energy sectors with a bolt-on acquisition costing up to £7 million.
The purchase of AVRS Systems Limited (AVRS), a specialist mechanical, electrical, instrumentation, control and automation (MEICA) design and build contractor, has been completed for an initial £4.5 million from the group's cash resources.